As much as I railed against costs, I do believe that profit begets motivation which begets quality. And I do think our system provides better drs and more options.
I'm in touch with a lot of guys from the UK on the autoimmune fb groups. One i've become quite close with. God darn is it tragic. The poor guy has been trying to get treatment for 2y, but he's beholden to the one neurologist he's allowed to see. Each appointment takes months, and they've been pushing it off by continuing to require him to get more tests. "Oh, you'll need a lip biopsy now before we can do anything. Next availibility is 4m from. Ok got that, hm maybe we need autonomic testing." He finally got approved to see some specialist in London, only to have his neuro and the specialist conspire to come up with a reason why he doesnt need IVIG. And there's zero recourse, nothing he can do, cant seek help elsewhere. He literally wants to off himself.
The problem, as I stated above, isnt quality, its cost, which suffers from the lack of transparency. In a typical for-profit system these market inefficiencies get arbed out due to competition, and price drops. Doesnt seem to happen in the us, too much friction.
Post Edited (dcd2103) : 11/9/2020 5:58:29 PM (GMT-7)